Attenuated Listeria monocytogenes mutant as a vaccine vector for the delivery of exogeneous antigens
Abstract:
Vaccines and compositions containing an attenuated L. monocytogenes prsA2 htrA deletion mutant for use in the presentation of foreign or exogenous antigens and in the treatment or prevention of diseases such as cancer or infectious disease are provided.
Information query
Patent Agency Ranking
0/0